vs
Harmony Biosciences Holdings, Inc.（HRMY）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
Harmony Biosciences Holdings, Inc.的季度营收约是LiveRamp Holdings, Inc.的1.1倍（$243.8M vs $212.2M），LiveRamp Holdings, Inc.净利率更高（18.8% vs 9.2%，领先9.6%），Harmony Biosciences Holdings, Inc.同比增速更快（21.1% vs 8.6%），过去两年Harmony Biosciences Holdings, Inc.的营收复合增速更高（25.6% vs 11.1%）
哈莫尼生物科学控股公司是一家处于商业化阶段的生物制药企业，专注于罕见神经及中枢神经系统疾病创新疗法的研发与商业化，核心产品针对发作性睡病等睡眠相关中枢神经系统病症，主要市场为美国。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
HRMY vs RAMP — 直观对比
营收规模更大
HRMY
是对方的1.1倍
$212.2M
营收增速更快
HRMY
高出12.5%
8.6%
净利率更高
RAMP
高出9.6%
9.2%
两年增速更快
HRMY
近两年复合增速
11.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $243.8M | $212.2M |
| 净利润 | $22.5M | $39.9M |
| 毛利率 | 71.9% | 71.9% |
| 营业利润率 | 15.8% | 18.6% |
| 净利率 | 9.2% | 18.8% |
| 营收同比 | 21.1% | 8.6% |
| 净利润同比 | -54.6% | 255.7% |
| 每股收益（稀释后） | $0.38 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HRMYRAMP
| Q4 25 | $243.8M | $212.2M | ||
| Q3 25 | $239.5M | $199.8M | ||
| Q2 25 | $200.5M | $194.8M | ||
| Q1 25 | $184.7M | $188.7M | ||
| Q4 24 | $201.3M | $195.4M | ||
| Q3 24 | $186.0M | $185.5M | ||
| Q2 24 | $172.8M | $176.0M | ||
| Q1 24 | $154.6M | $171.9M |
净利润HRMYRAMP
| Q4 25 | $22.5M | $39.9M | ||
| Q3 25 | $50.9M | $27.4M | ||
| Q2 25 | $39.8M | $7.7M | ||
| Q1 25 | $45.6M | $-6.3M | ||
| Q4 24 | $49.5M | $11.2M | ||
| Q3 24 | $46.1M | $1.7M | ||
| Q2 24 | $11.6M | $-7.5M | ||
| Q1 24 | $38.3M | $-5.4M |
毛利率HRMYRAMP
| Q4 25 | 71.9% | 71.9% | ||
| Q3 25 | 75.1% | 70.2% | ||
| Q2 25 | 81.0% | 70.1% | ||
| Q1 25 | 82.7% | 69.3% | ||
| Q4 24 | 73.0% | 71.9% | ||
| Q3 24 | 77.0% | 72.4% | ||
| Q2 24 | 81.4% | 70.6% | ||
| Q1 24 | 82.2% | 72.2% |
营业利润率HRMYRAMP
| Q4 25 | 15.8% | 18.6% | ||
| Q3 25 | 27.3% | 10.7% | ||
| Q2 25 | 24.0% | 3.7% | ||
| Q1 25 | 30.4% | -6.1% | ||
| Q4 24 | 27.7% | 7.5% | ||
| Q3 24 | 33.2% | 4.0% | ||
| Q2 24 | 12.4% | -3.0% | ||
| Q1 24 | 33.7% | -8.3% |
净利率HRMYRAMP
| Q4 25 | 9.2% | 18.8% | ||
| Q3 25 | 21.2% | 13.7% | ||
| Q2 25 | 19.8% | 4.0% | ||
| Q1 25 | 24.7% | -3.3% | ||
| Q4 24 | 24.6% | 5.7% | ||
| Q3 24 | 24.8% | 0.9% | ||
| Q2 24 | 6.7% | -4.3% | ||
| Q1 24 | 24.8% | -3.1% |
每股收益（稀释后）HRMYRAMP
| Q4 25 | $0.38 | $0.62 | ||
| Q3 25 | $0.87 | $0.42 | ||
| Q2 25 | $0.68 | $0.12 | ||
| Q1 25 | $0.78 | $-0.10 | ||
| Q4 24 | $0.85 | $0.17 | ||
| Q3 24 | $0.79 | $0.03 | ||
| Q2 24 | $0.20 | $-0.11 | ||
| Q1 24 | $0.67 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $775.3M | $403.4M |
| 总债务越低越好 | $163.7M | — |
| 股东权益账面价值 | $870.2M | $962.3M |
| 总资产 | $1.3B | $1.3B |
| 负债/权益比越低杠杆越低 | 0.19× | — |
8季度趋势，按日历期对齐
现金及短期投资HRMYRAMP
| Q4 25 | $775.3M | $403.4M | ||
| Q3 25 | $672.6M | $376.9M | ||
| Q2 25 | $565.3M | $371.1M | ||
| Q1 25 | $507.0M | $420.8M | ||
| Q4 24 | $467.2M | $384.3M | ||
| Q3 24 | $410.5M | $348.4M | ||
| Q2 24 | $346.9M | $342.7M | ||
| Q1 24 | $372.4M | $368.9M |
总债务HRMYRAMP
| Q4 25 | $163.7M | — | ||
| Q3 25 | $168.5M | — | ||
| Q2 25 | $172.1M | — | ||
| Q1 25 | $175.7M | — | ||
| Q4 24 | $179.3M | — | ||
| Q3 24 | $182.8M | — | ||
| Q2 24 | $186.4M | — | ||
| Q1 24 | $190.0M | — |
股东权益HRMYRAMP
| Q4 25 | $870.2M | $962.3M | ||
| Q3 25 | $835.1M | $943.8M | ||
| Q2 25 | $773.1M | $947.8M | ||
| Q1 25 | $720.5M | $948.9M | ||
| Q4 24 | $659.2M | $957.7M | ||
| Q3 24 | $596.8M | $932.1M | ||
| Q2 24 | $538.6M | $951.9M | ||
| Q1 24 | $515.4M | $949.1M |
总资产HRMYRAMP
| Q4 25 | $1.3B | $1.3B | ||
| Q3 25 | $1.2B | $1.2B | ||
| Q2 25 | $1.1B | $1.2B | ||
| Q1 25 | $1.1B | $1.3B | ||
| Q4 24 | $999.2M | $1.3B | ||
| Q3 24 | $928.1M | $1.2B | ||
| Q2 24 | $858.4M | $1.2B | ||
| Q1 24 | $847.0M | $1.2B |
负债/权益比HRMYRAMP
| Q4 25 | 0.19× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.22× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 0.27× | — | ||
| Q3 24 | 0.31× | — | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | 0.37× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $126.2M | — |
| 自由现金流经营现金流 - 资本支出 | $126.0M | — |
| 自由现金流率自由现金流/营收 | 51.7% | — |
| 资本支出强度资本支出/营收 | 0.0% | 0.1% |
| 现金转化率经营现金流/净利润 | 5.61× | — |
| 过去12个月自由现金流最近4个季度 | $347.9M | — |
8季度趋势，按日历期对齐
经营现金流HRMYRAMP
| Q4 25 | $126.2M | — | ||
| Q3 25 | $108.7M | $57.4M | ||
| Q2 25 | $79.3M | $-15.8M | ||
| Q1 25 | $34.0M | — | ||
| Q4 24 | $75.6M | $45.1M | ||
| Q3 24 | $70.5M | $55.6M | ||
| Q2 24 | $42.6M | $-9.3M | ||
| Q1 24 | $31.1M | — |
自由现金流HRMYRAMP
| Q4 25 | $126.0M | — | ||
| Q3 25 | $108.7M | $56.8M | ||
| Q2 25 | $79.3M | $-16.2M | ||
| Q1 25 | $33.9M | — | ||
| Q4 24 | $75.0M | $44.8M | ||
| Q3 24 | $70.5M | $55.4M | ||
| Q2 24 | $42.0M | $-9.6M | ||
| Q1 24 | $31.1M | — |
自由现金流率HRMYRAMP
| Q4 25 | 51.7% | — | ||
| Q3 25 | 45.4% | 28.4% | ||
| Q2 25 | 39.6% | -8.3% | ||
| Q1 25 | 18.3% | — | ||
| Q4 24 | 37.3% | 22.9% | ||
| Q3 24 | 37.9% | 29.8% | ||
| Q2 24 | 24.3% | -5.4% | ||
| Q1 24 | 20.1% | — |
资本支出强度HRMYRAMP
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.1% | 0.2% | ||
| Q4 24 | 0.3% | 0.1% | ||
| Q3 24 | 0.0% | 0.1% | ||
| Q2 24 | 0.4% | 0.1% | ||
| Q1 24 | 0.0% | 1.0% |
现金转化率HRMYRAMP
| Q4 25 | 5.61× | — | ||
| Q3 25 | 2.14× | 2.09× | ||
| Q2 25 | 1.99× | -2.04× | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 1.53× | 4.02× | ||
| Q3 24 | 1.53× | 32.10× | ||
| Q2 24 | 3.68× | — | ||
| Q1 24 | 0.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
